Results 1 to 10 of about 2,272 (172)
Reacción de hipersensibilidad a carboplatino no reversible mediante protocolo de desensibilización [PDF]
Ars Pharmaceutica (Internet), 2015 Platinum compounds are widely used in different tumors, being carboplatin indicated in ovarian carcinoma. The main carboplatin-dose limiting toxicity is the thrombocytopenia, however, sometimes we have seen hypersensitivity reactions that, although it is
F. Rueda, M. M. G. Santiago, M. Sempere
semanticscholar +9 more sources
Efecto del tratamiento con ácido fólico y carboplatino sobre la viabilidad de células no tumorales
Revista Argentina de Antropología BiológicaLas células cancerígenas están muy adaptadas y suelen ser resistentes a los agentes antitumorales, lo cual impedimenta una terapia efectiva contra el cáncer.
Sasha T. Manso González +3 more
semanticscholar +6 more sources
ACTA MEDICA PERUANA, 2016 Se presenta a una mujer peruana de 56 anos con cancer de ovario, estadio IIIC, tipo seroso, de alto grado, con citorreducion primaria optima, que recibio en primera linea carboplatino/paclitaxel or seis ciclos.
Brady Beltrán Gárate
semanticscholar +7 more sources
Farmacia Hospitalaria, 2007 Objective: To analyse carboplatin dosage in cancer patients in order to establish whether they are over or underdosed in comparison to the theoretical dose calculations during the first cycle of chemotherapy and to find a relationship between the ...
M. Palomo +5 more
semanticscholar +4 more sources
Revista de Medicina de la Universidad de Navarra, 2017 O. F. Fernández Hidalgo
semanticscholar +2 more sources
Innovations in the treatment of ovarian cancer. Analysis of the therapeutic development: from platinum to immunotherapy [PDF]
, 2017 Ovarian cancer is the seventh most common cancer in women. The therapeutic approach provides for an appropriate integration between surgery and chemotherapy.
Angius, Gesuino +4 more
core +1 more source
Current status of EGFR/ErbB inhibitors in non-small cell lung carcinoma [PDF]
, 2016 Durante los últimos 10 años hemos asistido a un cambio importante en el tratamiento del cáncer de pulmón (CP). El descubrimiento en 2004 de las mutaciones activadoras del receptor del factor de crecimiento epidérmico (EGFR) en alguno de los subgrupos ...
Esteban González, Emilio +1 more
core +1 more source
, 2006 Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and its medical and economical burden represents a serious matter in Europe and Usa, due to its high mortality rates and drug costs.
M. Eandi
semanticscholar +1 more source
Impact of combination chemotherapy on toxicity in ovarian cancer: Systematic revision of literature and meta-analysis [PDF]
, 2016 The purpose of this statistical analysis is to demonstrate the real advantages in terms of cost-benefit of combination chemotherapy compared with single-agent chemotherapy.
Bavetta, D. +5 more
core +1 more source
Carcinoma de ovario recurrente y platino sensible. A propósito de un caso clínico. [PDF]
, 2017 El cáncer de ovario es la cuarta causa de muerte por cáncer en la mujer. Esta enfermedad es, hoy día, una neoplasia que interfiere sumamente en la vida de las pacientes. Se presenta el caso de una paciente de 37 años que recibió múltiples tratamientos
Benítez Reguera, Mercedes
core